World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
7720
World Ranking
4780
National Ranking
2

Jean-Charles Grivel publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jean-Charles Grivel sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 142 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jean-Charles Grivel D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Charles Grivel sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jean-Charles Grivel is affiliated with Sidra Medicine in Qatar and has contributed extensively to research across multiple disciplines within medicine and molecular biology. Their work spans key areas including oncology, infectious diseases, genetics, and immunology, with a strong presence in interdisciplinary topics such as cancer immunotherapy and biomarkers, immune responses, and advanced biosensing techniques.

Their publication record features a number of recent papers, demonstrating engagement with current scientific challenges and emerging technologies. Notable publications include:

  • "Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis" (2020) in Stem Cells International
  • "Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy" (2021) in Molecular Cancer
  • "2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2" (2021) in Nano Today
  • "Immune Profiling and Multiplexed Label-Free Detection of 2D MXenes by Mass Cytometry and High-Dimensional Imaging" (2022) in Advanced Materials
  • "SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery" (2020) in Journal for ImmunoTherapy of Cancer

Jean-Charles Grivel frequently publishes in venues that include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Nano Today
  • Advanced Materials
  • Journal of Translational Medicine

The frequent co-authors collaborating with Jean-Charles Grivel include:

  • Giusy Gentilcore
  • Davide Bedognetti
  • Darawan Rinchai
  • Sara Deola
  • Selma Maacha

Their research covers several specialized topics:

  • SARS-CoV-2 and COVID-19 Research
  • Extracellular vesicles in disease
  • Cancer Immunotherapy and Biomarkers
  • Advanced biosensing and bioanalysis techniques
  • Immunotherapy and Immune Responses
  • MXene and MAX Phase Materials
  • CAR-T cell therapy research

Jean-Charles Grivel's main fields of study are Medicine and Biochemistry, Genetics and Molecular Biology, with a strong emphasis on molecular biology and oncology-related subjects. This reflects a broad and integrative approach to biomedical research, combining molecular mechanisms with clinical implications and novel materials science applications.

Best Publications

  • Semen-Derived Amyloid Fibrils Drastically Enhance HIV Infection

    Jan Münch;Elke Rücker;Ludger Ständker;Knut Adermann

  • Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance.

    Selma Maacha;Ajaz A. Bhat;Lizandra Jimenez;Afsheen Raza

  • CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis.

    Jean-Philippe Herbeuval;Jean-Charles Grivel;Adriano Boasso;Andrew W. Hardy

  • Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1

    Angélique Biancotto;Jean Charles Grivel;Sarah J. Iglehart;Christophe Vanpouille

  • CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.

    Jean-Charles Grivel;Leonid B. Margolis

  • Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis.

    Selma Maacha;Heba Sidahmed;Shana Jacob;Giusy Gentilcore

  • Biological and Technical Variables Affecting Immunoassay Recovery of Cytokines from Human Serum and Simulated Vaginal Fluid: A Multicenter Study

    Raina N. Fichorova;Nicola Richardson-Harman;Massimo Alfano;Laurent Belec

  • TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells.

    Jean-Philippe Herbeuval;Adriano Boasso;Jean-Charles Grivel;Andrew W. Hardy

  • Isolation and clonal analysis of human epidermal keratinocyte stem cells in long-term culture.

    Sandra Papini;Denise Cecchetti;Daniela Campani;Wendy Fitzgerald

  • CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue

    Michael L. Penn;Jean-Charles Grivel;Birgit Schramm;Mark A. Goldsmith

  • Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

    Jean-Charles Grivel;Robin J Shattock;Leonid B Margolis

  • Evidence of perturbations of the cytokine network in preterm labor

    Roberto Romero;Roberto Romero;Jean Charles Grivel;Adi L. Tarca;Piya Chaemsaithong;Piya Chaemsaithong

  • HIV-1–induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo

    Angélique Biancotto;Sarah J. Iglehart;Christophe Vanpouille;Cristian E. Condack

  • HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model

    Elisa Saba;Jean-Charles Grivel;Christophe Vanpouille;Beda Brichacek

  • Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides.

    Patricia S Fletcher;Julie Elliott;Jean-Charles Grivel;Leonid Margolis

  • Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency

    Svetlana Glushakova;Jean Charles Grivel;Wendy Fitzgerald;Andrew Sylwester

  • Acyclovir Is Activated into a HIV-1 Reverse Transcriptase Inhibitor in Herpesvirus-Infected Human Tissues

    Andrea Lisco;Christophe Vanpouille;Egor P. Tchesnokov;Jean Charles Grivel

  • Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy

    Ajaz A. Bhat;Sabah Nisar;Selma Maacha;Tatiana Correa Carneiro-Lobo

  • Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6

    Jean Charles Grivel;Yoshinori Ito;Giovanni Fagà;Fabio Santoro

  • Pathogenic Effects of Human Herpesvirus 6 in Human Lymphoid Tissue Ex Vivo

    Jean Charles Grivel;Fabio Santoro;Silvia Chen;Giovanni Fagá

  • Efficient Presentation of Multivalent Antigens Targeted to Various Cell Surface Molecules of Dendritic Cells and Surface Ig of Antigen-Specific B Cells

    Karine Serre;Patrick Machy;Jean-Charles Grivel;Gilles Jolly

  • Activation of T Lymphocytes in Atherosclerotic Plaques

    Jean-Charles Grivel;Oxana Ivanova;Natalia Pinegina;Paul S. Blank

Frequent Co-Authors

Leonid Margolis
Leonid Margolis National Institutes of Health
Paolo Lusso
Paolo Lusso National Institutes of Health
Peter A. Anton
Peter A. Anton University of California, Los Angeles
Robin J. Shattock
Robin J. Shattock Imperial College London
Mauro S. Malnati
Mauro S. Malnati Vita-Salute San Raffaele University
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
Matthew J. Dolan
Matthew J. Dolan San Antonio Military Medical Center
Philip M. Murphy
Philip M. Murphy National Institutes of Health
Sonia S. Hassan
Sonia S. Hassan Wayne State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology opens various career pathways, many of which intersect with healthcare professions like nursing. For those interested in entering the nursing field quickly, accelerated nurse practitioner programs offer fast-tracked education designed for individuals who already hold a bachelor’s degree in another area.

Beginners without a nursing background can consider online ADN programs for non nurses, which provide foundational knowledge as well as hands-on training. These programs are tailored for students transitioning into nursing from different fields, making them a viable option for immunology graduates seeking clinical roles.

For those aiming to start with a Bachelor of Science in Nursing, exploring the easiest accelerated nursing programs can help achieve licensure and career progression with less competitive entry requirements and manageable coursework.

Additionally, LPN programs easy to get into provide an accessible route into practical nursing careers, which can complement an immunology background by focusing on patient care and clinical support roles.

Best Scientists Citing Jean-Charles Grivel

Trending Scientists